CYP1A2 and aspiration pneumonitis: Systemic inflammation can cause a reduction in metabolism of clozapine via hepatic CYP1A2 enzymes,28 which can cause a rise in clozapine plasma concentration; this may increase the severity of plasma concentration-related side effects such as sedation and hypersalivation, in turn increasing the risk of aspiration pneumonia.